Smurfit Westrock (SW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
11 Mar, 2026Executive summary
Achieved strong operational and financial results in 2025, with $31.2B net sales, $4.9B adjusted EBITDA, and $1.5B adjusted free cash flow, exceeding synergy targets post-Combination.
Maintained a performance-driven, customer-centric culture, emphasizing safety, accountability, and continuous improvement.
Returned capital to shareholders via quarterly dividends, including a 5% increase in February 2026.
Announced a Medium-Term Plan through 2030 to guide disciplined capital allocation and drive improved financial performance.
Continued robust shareholder engagement and transparency, with over 450 investor meetings in 2025.
Voting matters and shareholder proposals
Election of 12 director nominees for one-year terms.
Advisory vote to approve named executive officer compensation.
Ratification of KPMG as independent auditor for 2026 and authorization for the Audit Committee to set remuneration.
Renewal of Board authority to issue shares and opt out of statutory pre-emption rights under Irish law.
Determination of price range for re-issuing treasury shares.
Board of directors and corporate governance
Board comprises 12 directors post-AGM, with 83% independence and a 50% gender split.
Board committees (Audit, Compensation, Nomination, Finance, Sustainability) are fully independent.
Annual board and committee evaluations, including an external review in 2025.
Shareholders holding 10%+ of shares can call special meetings; one class of voting stock with equal rights.
No poison pill or supermajority vote provisions beyond Irish law.
Latest events from Smurfit Westrock
- Q2 2026 delivered $8.0B sales, $88M net income, and $1.14B EBITDA with a 14.2% margin.SW
Q2 2026 - Net income fell to $63M on stable sales, with strong LATAM margins and positive outlook.SW
Q1 2026 - Targets $7bn Adjusted EBITDA and ~19% margin by 2030, with strong capital returns and global growth.SW
Investor presentation - AGM to vote on directors, compensation, auditor, and share issuance; board recommends approval.SW
Proxy Filing - Q4 net sales $7.58B, $4.94B Adjusted EBITDA; 2026 EBITDA guidance $5–$5.3B.SW
Q4 2025 - Q3 2025 delivered $8B sales, $1.3B EBITDA, $245M net income, and robust synergy-driven margins.SW
Q3 2025 - Q2 2025 saw strong sales and EBITDA, but restructuring costs led to a net loss.SW
Q2 2025 - Q1 2025 Adjusted EBITDA surged 163% year-over-year, with strong synergy and integration progress.SW
Q1 2025 - 2024 net sales hit $30.9B, adjusted EBITDA $4.7B, with strong synergy and dividend growth.SW
Q4 2024